PYPAF1 nonsense mutation in a patient with an unusual autoinflammatory syndrome -: Role of PYPAF1 in inflammation

被引:28
作者
Jéru, I
Hayrapetyan, H
Duquesnoy, P
Sarkisian, T
Amselem, S
机构
[1] Hop Henri Mondor, INSERM, U 654, F-94010 Creteil, France
[2] Natl Acad Sci, Yerevan, Armenia
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 02期
关键词
D O I
10.1002/art.21618
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To gain insight into the pathophysiology of an unusual autoinflammatory syndrome, in a patient of Armenian origin, that mimicked familial Mediterranean fever (FMF) but with episodes triggered by generalized exposure to cold, and to further elucidate the controversial function of the protein encoded by PYPAF1, whose mutations (exclusively missense to date) have been identified in 3 hereditary recurrent fever syndromes. Methods. The patient's DNA was screened for mutations in both MEFV, the gene responsible for FMF, and PYPAF1. The ability of different recombinant PYPAF1 isoforms, expressed in HEK 293 cells, to regulate NF-kappa B signaling was subsequently assessed. Results. No disease-causing mutation was found in MEFV. However, a nonsense mutation (p.Arg554X) was identified in PYPAF1; this defect resulted in a truncated protein lacking all leucine-rich repeats. Study of the wild-type and mutant PYPAF1 recombinant proteins revealed that PYPAF1 inhibited NF-kappa B proinflammatory pathways, and that the identified nonsense mutation impaired this property. Conclusion. These molecular and clinical findings, together with the clinical manifestations in the patient, which call into question the current nosology of the hereditary recurrent fever syndromes, are consistent with the hypothesis that PYPAF1 acts as an inhibitor of NF-kappa B signaling. They also provide a clear elucidation of the functional consequences of this nonsense PYPAF1 mutation not previously described in the literature, which result in a partial loss of function and may thereby explain the pathophysiology of the autoinflammatory syndrome observed in this patient.
引用
收藏
页码:508 / 514
页数:7
相关论文
共 33 条
[21]   NODs: Intracellular proteins involved in inflammation and apoptosis [J].
Inohara, N ;
Nuñez, G .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (05) :371-382
[22]   Criteria for the diagnosis of familial Mediterranean fever [J].
Livneh, A ;
Langevitz, P ;
Zemer, D ;
Zaks, N ;
Kees, S ;
Lidar, T ;
Migdal, A ;
Padeh, S ;
Pras, M .
ARTHRITIS AND RHEUMATISM, 1997, 40 (10) :1879-1885
[23]   PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-κB [J].
Manji, GA ;
Wang, L ;
Geddes, BJ ;
Brown, M ;
Merriam, S ;
Al-Garawi, A ;
Mak, S ;
Lora, JM ;
Briskin, M ;
Jurman, M ;
Cao, J ;
DiStefano, PS ;
Bertin, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :11570-11575
[24]   ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells [J].
Masumoto, J ;
Taniguchi, S ;
Ayukawa, K ;
Sarvotham, H ;
Kishino, T ;
Niikawa, N ;
Hidaka, E ;
Katsuyama, T ;
Higuchi, T ;
Sagara, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :33835-33838
[25]   Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU [J].
Neven, B ;
Callebaut, I ;
Prieur, AM ;
Feldmann, J ;
Bodemer, C ;
Lepore, L ;
Derfalvi, B ;
Benjaponpitak, S ;
Vesely, R ;
Sauvain, MJ ;
Oertle, S ;
Allen, R ;
Morgan, G ;
Borkhardt, A ;
Hill, C ;
Gardner-Medwin, J ;
Fischer, A ;
Saint Basile, GD .
BLOOD, 2004, 103 (07) :2809-2815
[26]   Cutting edge:: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-κB suppressive properties [J].
O'Connor, W ;
Harton, JA ;
Zhu, XS ;
Linhoff, MW ;
Ting, JPY .
JOURNAL OF IMMUNOLOGY, 2003, 171 (12) :6329-6333
[27]  
Sarkisian T., 2005, Current Drug Targets - Inflammation and Allergy, V4, P113, DOI 10.2174/1568010053622885
[28]   The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor κB activation pathways [J].
Stehlik, C ;
Fiorentino, L ;
Dorfleutner, A ;
Bruey, JM ;
Ariza, EM ;
Sagara, J ;
Reed, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (12) :1605-1615
[29]   Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome -: A low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa [J].
Stojanov, S ;
Lohse, P ;
Lohse, P ;
Hoffmann, F ;
Renner, ED ;
Zellerer, S ;
Kéry, A ;
Shin, YS ;
Haas, D ;
Hoffmann, GF ;
Belohradsky, BH .
ARTHRITIS AND RHEUMATISM, 2004, 50 (06) :1951-1958
[30]   Clinical evaluation of a reverse hybridization assay for the molecular detection of twelve MEFV gene mutations [J].
Tchernitchko, D ;
Legendre, M ;
Delahaye, A ;
Cazeneuve, C ;
Niel, F ;
Goosens, M ;
Amselem, S ;
Girodon, E .
CLINICAL CHEMISTRY, 2003, 49 (11) :1942-1945